Cimatron Reports Record Second Quarter Revenues of $11.0 million in Q2 2013 $1.6M non-GAAP operating profit in Q2/13

GIVAT SHMUEL, Israel, Aug. 13, 2013 /PRNewswire/ -- Cimatron Limited (NASDAQ: CIMT), a leading provider of integrated CAD/CAM software solutions for the toolmaking and manufacturing industries, today announced financial results for the second quarter and first six months of 2013. 

Highlights of Cimatron's results for the second quarter of 2013 include the following:

  • Record second quarter revenues of $11.0M
  • 89% gross margin and 14% operating margin on a non-GAAP basis
  • $0.13 non-GAAP EPS
  • $3.4M increase in net cash, to $7.1M

Commenting on the results, Danny Haran, President and Chief Executive Officer of Cimatron, noted, "We are pleased to report yet another record second quarter in terms of revenues, with solid operating profit of $1.6 million and a strong increase in net cash."

"A new cooperation agreement with Moldex3D was recently signed, to provide new simulation tools for assessing the efficiency of mold cooling systems. This technology will be part of a new add-on offering planned to be delivered on the next version of CimatronE. While the prime target users for these new tools are mold makers using 3D-printed conformal cooling systems, it is also applicable to traditional cooling channels, significantly expanding the CimatronE target market in the near and medium term."

"In addition, we continue to invest more in sales and marketing, as well as in R&D. This explains a large portion of the increase in operating expenses in this quarter compared to the second quarter of 2012. We believe such investments are well warranted and will contribute to enhancing sales in the coming quarters and years." concluded Mr. Haran.

The following provides details on Cimatron's GAAP and non-GAAP results for the second quarter and first six months of 2013:

GAAP:
Revenues for the second quarter of 2013 were $11.0 million, compared to $10.6 million recorded in the second quarter of 2012. For the first six months of 2013, revenues were $21.2 million, compared to $20.5 million in the same period of 2012. 

Gross Profit for the second quarter of 2013 was $9.6 million, as compared to $9.7 million in the same period in 2012. Gross margin in the second quarter of 2013 was 87% of revenues, compared to 91% in the second quarter of 2012. For the first six months of 2013, gross profit was $18.5 million, compared to $18.1 million in the same period of 2012. Gross margin for the six months ended June 30, 2013 was 87% of revenues, compared to a gross margin of 89% of revenues for the first six months of 2012.

Operating profit in the second quarter of 2013 was $1.4 million, as compared to $1.8 million in the same period in 2012. In the first six months of 2013, Cimatron recorded an operating profit of $2.2 million, compared to an operating profit of $2.7 million in the first six months of 2012. 

The higher gross and operating margins in the second quarter and first six months of 2012 as compared to the parallel periods of 2013 reflect the agreement with the Office of Chief Scientist in the Israeli Ministry of Industry, Trade and Labor (OCS), that was announced last year. As a result of that agreement, the Company recorded additional one-time income of approximately $0.4M in the second quarter of 2012, reflected as a lower cost of revenue in the GAAP Statements of Income for the second quarter and first six months of 2012. Such income was excluded from the non-GAAP results for the second quarter and first six months of 2012, in order to ensure that comparisons to comparable periods of other years better reflect our ongoing operations.

In addition to increased investment in R&D and sales and marketing, foreign currency exchange rates also accounted for the increase in operating expenses in the second quarter of 2013 compared to the second quarter of 2012.

Net Profit for the second quarter of 2013 was $1.0 million, or $0.11 per diluted share, compared to a net profit of $1.0 million, or $0.11 per diluted share, recorded in the same quarter of 2012.  In the first six months of 2013, net profit was $1.6 million, or $0.17 per diluted share, compared to a net profit of $1.8 million, or $0.20 per diluted share, in the first six months of 2012. 

Non-GAAP:
Revenues for the second quarter of 2013 were $11.0 million, compared to $10.6 million recorded in the second quarter of 2012. For the first six months of 2013, revenues were $21.2 million, compared to $20.5 million in the same period of 2012. 

Gross Profit for the second quarter of 2013 was $9.8 million, as compared to $9.4 million in the same period in 2012. Gross margin in the second quarter of 2013 was 89% of revenues, the same as in the second quarter of 2012. In the first six months of 2013, gross profit was $18.8 million, compared to $18.0 million in the first six months of 2012. Gross margin for the six months ended June 30, 2013 was 89% of revenues, compared to a gross margin of 88% of revenues for the first six months of 2012.

Operating Profit in the second quarter of 2013 was $1.6 million, as compared to $1.7 million in the same period in 2012. In the first six months of 2013, Cimatron recorded an operating profit of $2.6 million, compared to an operating profit of $2.8 million in the first six months of 2012.

In addition to increased investment in R&D and sales and marketing, foreign currency exchange rates also accounted for the increase in operating expenses in the second quarter of 2013 compared to the second quarter of 2012.

Net profit for the second quarter of 2013 was $1.2 million, or $0.13 per diluted share, compared to a net profit of $1.0 million, or $0.11 per diluted share, recorded in the same quarter of 2012. In the first six months of 2013, net profit was $1.9 million, or $0.20 per diluted share, compared to a net profit of $2.0 million, or $0.22 per diluted share, in the first six months of 2012.

Conference Call
Cimatron's management will host a conference call today, August 13, 2013, at 9:00 EDT, 16:00 Israel time. On the call, management will review and discuss the results, and will answer questions by investors.

To participate, please call one of the following teleconferencing numbers. Please begin placing your call at least 5 minutes before the conference call commences.

USA: +1-888-407-2553

International: +972-3-9180610

Israel: 03-9180610

For those unable to listen to the live call, a replay of the call will be available beginning on the day after the call at the investor relations section of Cimatron's website, at: www.cimatron.com

Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income included herein. Non-GAAP financial measures consist of GAAP financial measures adjusted to include recognition of deferred revenues of acquired companies and to exclude amortization of acquired intangible assets and deferred income tax, as well as certain business combination and other accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-cash charges and other items that are considered by management to be outside of our core operating results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.

Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. We believe that these non-GAAP measures help investors to understand our current and future operating performance, especially as our two most recent acquisitions have resulted in amortization and non-cash items that have had a material impact on our GAAP results. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies.

About Cimatron
With 30 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM software solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles and ultimately shorten product delivery time.

The Cimatron product line includes the CimatronE and GibbsCAM brands with software solutions for mold design, die design, electrode design, 2.5 to 5 Axis milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.

Cimatron's shares are publicly traded on the NASDAQ under the symbol CIMT. For more information, please visit Cimatron's web site at: http://www.cimatron.com

Safe Harbor Statement

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

Company Contact:

Investor Relations contact

Ilan Erez, Chief Financial Officer

Ehud Helft/Kenny Green

Cimatron Ltd.

CCG Investor Relations

Tel.; 972-73-237-0114

Tel: (US) 1 646 201 9246

Email: ilane@cimatron.com

Email: Cimatron@ccgisrael.com

CIMATRON LIMITED

CONSOLIDATED STATEMENTS OF INCOME

(US Dollars in thousands, except for per share data)




















Three months ended


Six months ended







June 30,


June 30,







2013


2012


2013


2012














Total revenue

11,039


10,608


21,197


20,494














Total cost of revenue

1,391


934


2,717


2,352














Gross profit

9,648


9,674


18,480


18,142














   Research and development expenses

1,758


1,629


3,486


3,322














   Selling, general and administrative expenses

6,477


6,215


12,803


12,101

Operating income 

1,413


1,830


2,191


2,719














   Financial expenses, net

(40)


(205)


(24)


(92)














   Taxes on income

(377)


(626)


(569)


(800)














   Other


3


(4)


5


11














Net income 

999


995


1,603


1,838














   Less: Net (income) loss attributable to the noncontrolling interest

3


3


3


(9)














Net income attributable to Cimatron's shareholders

$ 1,002


$ 998


$ 1,606


$ 1,829









Net income per share - basic and diluted

$ 0.11


$ 0.11


$ 0.17


$ 0.20














Weighted average number of shares outstanding






















Basic EPS (in thousands)

9,362


9,309


9,355


9,305















Diluted EPS (in thousands)

9,362


9,329


9,360


9,323

 

CIMATRON LIMITED


RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION


(US Dollars in thousands, except for per share data)






































Three months ended


Six months ended








June 30,


June 30,










2013






2012






2013






2012










GAAP


Adj.


NON-GAAP


GAAP


Adj.


NON-GAAP


GAAP


Adj.


NON-GAAP


GAAP


Adj.


NON-GAAP
































Total revenue 

11,039


-


11,039


10,608


-


10,608


21,197


-


21,197


20,494


-


20,494
































Total cost of revenue 

1,391




1,244


934




1,206


2,717




2,423


2,352




2,477




Non-cash amortization of acquired intangible assets




(147)






(147)






(294)






(294)






One-time income from OCS agreement










419












419


































Gross profit

9,648


147


9,795


9,674


(272)


9,402


18,480


294


18,774


18,142


(125)


18,017
































   Research and development expenses

1,758


-


1,758


1,629


-


1,629


3,486


-


3,486


3,322


-


3,322
































   Selling, general and administrative expenses (1)

6,477


(32)


6,445


6,215


(98)


6,117


12,803


(85)


12,718


12,101


(197)


11,904


Operating income 

1,413


179


1,592


1,830


(174)


1,656


2,191


379


2,570


2,719


72


2,791
































   Financial expenses, net

(40)


-


(40)


(205)


-


(205)


(24)


-


(24)


(92)


-


(92)
































   Taxes on income (2)

(377)


-


(377)


(626)


209


(417)


(569)


(91)


(660)


(800)


118


(682)
































   Other 

3


-


3


(4)


-


(4)


5


-


5


11


-


11






























































Net income 

999


179


1,178


995


35


1,030


1,603


288


1,891


1,838


190


2,028
































   Less: Net (income) loss attributable to the noncontrolling interest

3


-


3


3


-


3


3


-


3


(9)


-


(9)
































Net income attributable to Cimatron's shareholders

$ 1,002


$ 179


$ 1,181


$ 998


$ 35


$ 1,033


$ 1,606


$ 288


$ 1,894


$ 1,829


$ 190


$ 2,019



























Net income per share - basic and diluted 

$ 0.11




$ 0.13


$ 0.11




$ 0.11


$ 0.17




$ 0.20


$ 0.20




$ 0.22
































Weighted average number of shares outstanding
























































Basic EPS (in thousands)

9,362




9,362


9,309




9,309


9,355




9,355


9,305




9,305

































Diluted EPS (in thousands)

9,362




9,362


9,329




9,329


9,360




9,360


9,323




9,323
































(1) Non-GAAP adjustment to exclude non-cash amortization of acquired intangible assets. 





















(2) Non-GAAP adjustment to exclude the effect of deferred taxes and other tax provisions.






















 

CIMATRON LIMITED

CONSOLIDATED BALANCE SHEETS

(US Dollars in thousands)


















June 30,


December 31,








2013


2012
















ASSETS





CURRENT ASSETS:






Total cash, cash equivalents and short-term investments


$            9,577


$        11,903


Trade receivables


5,705


6,049


Other current assets


2,339


1,788



Total current assets


17,621


19,740























Deposits with insurance companies and severance pay fund


3,418


3,296



Net property and equipment


912


875













Net other assets


10,085


10,499














Total assets


$          32,036


$        34,410
















LIABILITIES AND SHAREHOLDERS' EQUITY





CURRENT LIABILITIES:






Short-term bank credit


$            2,500


$                1


Trade payables


1,265


1,169


Accrued expenses and other liabilities


5,272


7,204


Deferred revenues


6,012


2,843



Total current liabilities


15,049


11,217











LONG-TERM LIABILITIES:






Accrued severance pay


4,677


4,453


Deferred tax liability


185


275


   Total long-term liabilities


4,862


4,728


Total shareholders' equity


12,125


18,465




Total liabilities and shareholders' equity


$          32,036


$        34,410

 

CIMATRON LIMITED

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY 

(US Dollars in thousands)
























Accumulated other comprehensive income (loss)






Comprehensive income (loss)



Noncontrolling Interest


Share capital


Additional paid-in capital



Retained earnings (accumulated deficit)


Treasury stock



Total shareholders' equity

Balance at December 31, 2012

$                28


$         313


$     18,906


$                   (6)


$               (24)


$        (752)




$         18,465

Changes during the six months ended June 30,
2013:
















Net income

(3)








1,606




1,603


1,603

Cash distribution to shareholders





(7,916)










(7,916)

Exercise of share options





47










47

Unrealized gain on derivative instruments







(1)






(1)


(1)

Other  







(46)






(46)


(46)

Foreign currency translation adjustment







(27)






(27)


(27)

Total comprehensive income













1,529



Balance at June 30, 2013

$                25


$         313


$     11,037


$                 (80)


$           1,582


$        (752)




$         12,125

 

CIMATRON LIMITED

STATEMENTS OF CASH FLOWS

(US Dollars in thousands)












Six months ended





June 30,





2013


2012








Cash flows from operating activities:




Net income 



$        1,603


$        1,838








Adjustments to reconcile net income 




   to net cash provided by operating activities:




Depreciation and amortization


557


686

Increase (decrease) in accrued severance pay

232


(476)

Loss on disposal of businesses – discontinued operations

-


(2)

Deferred taxes, net



(90)


(180)








Changes in assets and liabilities:




Decrease (increase) in accounts receivable and prepaid expenses

(258)


528

Increase in inventory



(8)


(1)

Decrease (increase) in deposits with insurance companies and severance pay fund

(122)


5

Increase in trade payables, accrued expenses and other liabilities

1,264


2,329

Net cash provided by operating activities

3,178


4,727








Cash flows from investing activities:




Proceeds from sale of property and equipment

9


1

Purchase of property and equipment

(83)


(126)

Net cash used in investing activities

(74)


(125)















Cash flows from financing activities:




Short-term bank credit


2,499


(58)

Long-term bank credit


-


(7)

Cash distribution to shareholders




(7,916)


(1,611)

Proceeds from issuance of shares upon exercise of options 

47


40

Net cash used in financing activities

(5,370)


(1,636)















Net increase (decrease) in cash and cash equivalents

(2,266)


2,966

Effect of exchange rate changes on cash

(60)


(68)

Cash and cash equivalents at beginning of period

11,903


11,787

Cash and cash equivalents at end of period

$        9,577


$      14,685








Appendix A - Non-cash transactions




Purchase of property on credit

$           122


$            89

SOURCE Cimatron Limited



RELATED LINKS
http://www.cimatron.com

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.